Medthority
@medthority.bsky.social
Get closer to the conversations that matter in medicine, with our award-winning #MedEd platform. From podcast episodes to videos and articles, our channel showcases the latest resources on medthority.com #MedSky
For healthcare professionals only.
For healthcare professionals only.
How do you navigate the complexities of diagnosing #alopeciaareata across different racial and ethnic groups? Listen to Brittany Craiglow and Amy McMichael discuss clinical and trichoscopic features, common misdiagnoses, and the role of SALT scoring #MedSky #DermSky
ow.ly/k9Gw50Xz0oO
ow.ly/k9Gw50Xz0oO
November 28, 2025 at 11:57 AM
How do you navigate the complexities of diagnosing #alopeciaareata across different racial and ethnic groups? Listen to Brittany Craiglow and Amy McMichael discuss clinical and trichoscopic features, common misdiagnoses, and the role of SALT scoring #MedSky #DermSky
ow.ly/k9Gw50Xz0oO
ow.ly/k9Gw50Xz0oO
What’s missing in current clinical guidelines on prostate cancer that every new specialist should know? Alicia Morgans shares her opinion at #ESMO25, including the importance of mitigating the risk of comorbidities #MedSky #OncSky #ProstateCancer #Movember
ow.ly/ap8W50XyGu2
ow.ly/ap8W50XyGu2
November 27, 2025 at 4:09 PM
What’s missing in current clinical guidelines on prostate cancer that every new specialist should know? Alicia Morgans shares her opinion at #ESMO25, including the importance of mitigating the risk of comorbidities #MedSky #OncSky #ProstateCancer #Movember
ow.ly/ap8W50XyGu2
ow.ly/ap8W50XyGu2
What are the #NMIBC updates from #ESMO25 you need to know? @ashishkamatmd.bsky.social and Paolo Gontero unpack the latest insights from last month's event, including the impact of BCG therapy shortages and how AI-driven pathology is reshaping risk stratification #MedSky #OncSky
ow.ly/LPaL50Xy4ZJ
ow.ly/LPaL50Xy4ZJ
November 26, 2025 at 1:08 PM
What are the #NMIBC updates from #ESMO25 you need to know? @ashishkamatmd.bsky.social and Paolo Gontero unpack the latest insights from last month's event, including the impact of BCG therapy shortages and how AI-driven pathology is reshaping risk stratification #MedSky #OncSky
ow.ly/LPaL50Xy4ZJ
ow.ly/LPaL50Xy4ZJ
What role does surgery play in the management of desmoid tumors? Watch Maya Niethard share the surgeon's perspective and key considerations when deciding whether surgery should be recommended to a patient at #DGHO25 #MedSky #OncSky #Oncology
ow.ly/AhsY50XxBqq
ow.ly/AhsY50XxBqq
November 25, 2025 at 4:35 PM
What role does surgery play in the management of desmoid tumors? Watch Maya Niethard share the surgeon's perspective and key considerations when deciding whether surgery should be recommended to a patient at #DGHO25 #MedSky #OncSky #Oncology
ow.ly/AhsY50XxBqq
ow.ly/AhsY50XxBqq
Did you know Medthority only publishes independent #medicaleducation? We bring you trusted resources across a range of specialties, making the latest evidence and insights easy to access as part of your daily routine #MedSky #MedEd #IME
ow.ly/HO4B50XwYoS
ow.ly/HO4B50XwYoS
November 24, 2025 at 4:30 PM
Did you know Medthority only publishes independent #medicaleducation? We bring you trusted resources across a range of specialties, making the latest evidence and insights easy to access as part of your daily routine #MedSky #MedEd #IME
ow.ly/HO4B50XwYoS
ow.ly/HO4B50XwYoS
Get closer to the conversations that matter from #EANO2025 with our concise summary on NF1-PN care. From the current treatment landscape to the latest advances on the horizon, catch up with the updates you need to know on Medthority now #MedSky #OncSky #NeuroSky
ow.ly/FZJk50XuOQH
ow.ly/FZJk50XuOQH
November 21, 2025 at 9:26 AM
Get closer to the conversations that matter from #EANO2025 with our concise summary on NF1-PN care. From the current treatment landscape to the latest advances on the horizon, catch up with the updates you need to know on Medthority now #MedSky #OncSky #NeuroSky
ow.ly/FZJk50XuOQH
ow.ly/FZJk50XuOQH
What do you think about Medthority? Let us know what matters to you in #medicaleducation, and what we can do better! Share your views in just 5 minutes with our quick survey. Your feedback is hugely valuable to help us improve our resources #MedSky #MedEd
ow.ly/PFGv50XuOla
ow.ly/PFGv50XuOla
November 20, 2025 at 4:40 PM
What do you think about Medthority? Let us know what matters to you in #medicaleducation, and what we can do better! Share your views in just 5 minutes with our quick survey. Your feedback is hugely valuable to help us improve our resources #MedSky #MedEd
ow.ly/PFGv50XuOla
ow.ly/PFGv50XuOla
How can you help patients and caregivers navigate the impacts of an #NMIBC diagnosis? Host @ashishkamatmd.bsky.social talks to husband and wife Doug and Camille in the latest episode of Expert voices - Navigating NMIBC. Listen now for first-hand patient insights #MedSky #MedEd
ow.ly/3JlR50Xu1b6
ow.ly/3JlR50Xu1b6
November 19, 2025 at 12:45 PM
How can you help patients and caregivers navigate the impacts of an #NMIBC diagnosis? Host @ashishkamatmd.bsky.social talks to husband and wife Doug and Camille in the latest episode of Expert voices - Navigating NMIBC. Listen now for first-hand patient insights #MedSky #MedEd
ow.ly/3JlR50Xu1b6
ow.ly/3JlR50Xu1b6
Catch up with the latest trial data on HLH/MAS presented at #ACR25, including biomarker-driven breakthroughs and early diagnostic strategies, free and on demand with Medthority #MedSky #MedEd #RareDisease #Hematology #Rheumatology #RheumSky
ow.ly/pq7y50XsOPg
ow.ly/pq7y50XsOPg
November 17, 2025 at 2:04 PM
Catch up with the latest trial data on HLH/MAS presented at #ACR25, including biomarker-driven breakthroughs and early diagnostic strategies, free and on demand with Medthority #MedSky #MedEd #RareDisease #Hematology #Rheumatology #RheumSky
ow.ly/pq7y50XsOPg
ow.ly/pq7y50XsOPg
We're nearly halfway through #Movember! Head over to Medthority to get closer to the conversations that matter in men's health with our Prostate Cancer Nexus, designed to support your clinical decisions #MedSky #ProstateCancer #MensHealth #MedEd
ow.ly/CWTe50XrGsC
ow.ly/CWTe50XrGsC
November 14, 2025 at 1:18 PM
We're nearly halfway through #Movember! Head over to Medthority to get closer to the conversations that matter in men's health with our Prostate Cancer Nexus, designed to support your clinical decisions #MedSky #ProstateCancer #MensHealth #MedEd
ow.ly/CWTe50XrGsC
ow.ly/CWTe50XrGsC
Do you care for people with a rare disease? Navigate these complex conditions with the latest congress highlights and expert opinions on a range of diseases, from HLH/MAS to NF1 #MedSky #RareDisease #MedEd
ow.ly/Oc0Q50Xrf4X
ow.ly/Oc0Q50Xrf4X
November 13, 2025 at 5:11 PM
Do you care for people with a rare disease? Navigate these complex conditions with the latest congress highlights and expert opinions on a range of diseases, from HLH/MAS to NF1 #MedSky #RareDisease #MedEd
ow.ly/Oc0Q50Xrf4X
ow.ly/Oc0Q50Xrf4X
🫁 This #LungCancerAwarenessMonth, catch up with the latest trial data from #ESMO25 on non-small-cell lung cancer (NSCLC). From treatment guidance to "reassuring" trial outcomes, get the updates you need to know on Medthority #MedSky #LungCancer
ow.ly/fnwp50XqsyE
ow.ly/fnwp50XqsyE
November 12, 2025 at 1:02 PM
🫁 This #LungCancerAwarenessMonth, catch up with the latest trial data from #ESMO25 on non-small-cell lung cancer (NSCLC). From treatment guidance to "reassuring" trial outcomes, get the updates you need to know on Medthority #MedSky #LungCancer
ow.ly/fnwp50XqsyE
ow.ly/fnwp50XqsyE
With new treatment options and assessment tools emerging, make sure your #alopeciaareata (AA) patients are getting the best possible care with expert insights in our NEW podcast series, Alopecia Areata in Conversation #MedSky #DermSky
ow.ly/vv1F50Xq2pE
ow.ly/vv1F50Xq2pE
November 11, 2025 at 4:02 PM
With new treatment options and assessment tools emerging, make sure your #alopeciaareata (AA) patients are getting the best possible care with expert insights in our NEW podcast series, Alopecia Areata in Conversation #MedSky #DermSky
ow.ly/vv1F50Xq2pE
ow.ly/vv1F50Xq2pE
Did you know you can watch exclusive Medthority videos on YouTube? Head over to our channel for expert perspectives on a range of specialties, from congress highlights at #ESMO25 to insights on shared decision-making in atrial fibrillation #MedSky #MedEd
ow.ly/fult50Xn2wX
ow.ly/fult50Xn2wX
November 10, 2025 at 2:22 PM
Did you know you can watch exclusive Medthority videos on YouTube? Head over to our channel for expert perspectives on a range of specialties, from congress highlights at #ESMO25 to insights on shared decision-making in atrial fibrillation #MedSky #MedEd
ow.ly/fult50Xn2wX
ow.ly/fult50Xn2wX
What does Félix Guerrero-Ramos think of upcoming shifts in clinical practice when managing #NMIBC? Guerrero-Ramos discusses what he’d like to see in future guidelines, including biomarker selection and better patient classification, at #ESMO25 #MedSky #OncSky
ow.ly/pX2E50XooEi
ow.ly/pX2E50XooEi
November 7, 2025 at 2:48 PM
What does Félix Guerrero-Ramos think of upcoming shifts in clinical practice when managing #NMIBC? Guerrero-Ramos discusses what he’d like to see in future guidelines, including biomarker selection and better patient classification, at #ESMO25 #MedSky #OncSky
ow.ly/pX2E50XooEi
ow.ly/pX2E50XooEi
How is the NMIBC treatment landscape shifting? Listen to Ashish Kamat host expert discussions with Roger Li, Joshua Meeks, and Fred Witjes in the latest episodes of our new podcast series, for insights that fit into your busy schedule #MedSky #BladderCancer #MedicalPodcast
ow.ly/c9vI50XnW2P
ow.ly/c9vI50XnW2P
November 6, 2025 at 4:58 PM
How is the NMIBC treatment landscape shifting? Listen to Ashish Kamat host expert discussions with Roger Li, Joshua Meeks, and Fred Witjes in the latest episodes of our new podcast series, for insights that fit into your busy schedule #MedSky #BladderCancer #MedicalPodcast
ow.ly/c9vI50XnW2P
ow.ly/c9vI50XnW2P
Get closer to the conversations that are changing clinical practice with our key highlights from #ESMO25. From summaries of the latest trial data to expert interviews, catch up with insights on bladder, prostate, and lung cancer care #MedSky #OncSky
ow.ly/Ho3q50Xnaux
ow.ly/Ho3q50Xnaux
November 5, 2025 at 3:44 PM
Get closer to the conversations that are changing clinical practice with our key highlights from #ESMO25. From summaries of the latest trial data to expert interviews, catch up with insights on bladder, prostate, and lung cancer care #MedSky #OncSky
ow.ly/Ho3q50Xnaux
ow.ly/Ho3q50Xnaux
Did you miss DGHO 2025? Stay up to date with insights from Bernd Kasper and Maya Niethard on desmoid tumor care, from diagnostic assessment and patient communication to management from a surgeon's perspective #MedSky #MedEd #OncSky
ow.ly/bPjN50XmEca
ow.ly/bPjN50XmEca
November 4, 2025 at 5:22 PM
Did you miss DGHO 2025? Stay up to date with insights from Bernd Kasper and Maya Niethard on desmoid tumor care, from diagnostic assessment and patient communication to management from a surgeon's perspective #MedSky #MedEd #OncSky
ow.ly/bPjN50XmEca
ow.ly/bPjN50XmEca
What are the main challenges in NF1-PN care and how might the evolving treatment landscape address unmet needs? Watch expert reflections from Said Farschtschi and Dusica Babovic-Vuksanovic at #EANO2025 #MedSky #NeuroSky
ow.ly/GwXw50XlTn0
ow.ly/GwXw50XlTn0
November 3, 2025 at 4:14 PM
What are the main challenges in NF1-PN care and how might the evolving treatment landscape address unmet needs? Watch expert reflections from Said Farschtschi and Dusica Babovic-Vuksanovic at #EANO2025 #MedSky #NeuroSky
ow.ly/GwXw50XlTn0
ow.ly/GwXw50XlTn0
How can we combat the myasthenic crisis? Listen to Tobias Ruck and Nils Erik Gilhus share their clinical experience of MG, with this compelling case study to help you identify early red flags and understand the importance of timely intervention #MedSky #NeuroSky
https://ow.ly/F9Tq50XkwHb
https://ow.ly/F9Tq50XkwHb
October 31, 2025 at 3:01 PM
How are HRR mutations reshaping care pathways in mPC? Tune in to the first 5 episodes of our NEW podcast series to hear insights from host Alicia Morgans and guests on advances in HRR testing and the genetic landscape of mCRPC #MedSky #OncSky #ProstateCancer
ow.ly/FZLx50XkjTo
ow.ly/FZLx50XkjTo
October 30, 2025 at 1:14 PM
How are HRR mutations reshaping care pathways in mPC? Tune in to the first 5 episodes of our NEW podcast series to hear insights from host Alicia Morgans and guests on advances in HRR testing and the genetic landscape of mCRPC #MedSky #OncSky #ProstateCancer
ow.ly/FZLx50XkjTo
ow.ly/FZLx50XkjTo
This #WorldStrokeDay, get the updates you need to know with our expert podcast series, Thrombosis in Conversation, hosted by @gbarnesmd.bsky.social. Stay ahead with highlights from #ESC2025, plus insights from Deborah Siegal on optimizing treatment duration #MedSky #CardioSky
ow.ly/hh0S50XjNC4
ow.ly/hh0S50XjNC4
October 29, 2025 at 3:14 PM
This #WorldStrokeDay, get the updates you need to know with our expert podcast series, Thrombosis in Conversation, hosted by @gbarnesmd.bsky.social. Stay ahead with highlights from #ESC2025, plus insights from Deborah Siegal on optimizing treatment duration #MedSky #CardioSky
ow.ly/hh0S50XjNC4
ow.ly/hh0S50XjNC4
What is Nick James’ opinion on this ‘hotly debated topic’ in #prostatecancer care discussed at #ESMO25? We spoke to James about treatment options, improving access, and the future of AI-assisted healthcare, available to watch now on Medthority #MedSky #MedEd #OncSky
ow.ly/pyEs50Xj2p6
ow.ly/pyEs50Xj2p6
October 28, 2025 at 2:04 PM
What is Nick James’ opinion on this ‘hotly debated topic’ in #prostatecancer care discussed at #ESMO25? We spoke to James about treatment options, improving access, and the future of AI-assisted healthcare, available to watch now on Medthority #MedSky #MedEd #OncSky
ow.ly/pyEs50Xj2p6
ow.ly/pyEs50Xj2p6
Get the latest insights from #DGHO2025 over on our YouTube channel! Watch Bernd Kasper discuss the most significant unmet needs and the importance of understanding the lived experience of people with desmoid tumors #MedSky #OncSky
ow.ly/e52g50XicbB
ow.ly/e52g50XicbB
October 27, 2025 at 10:07 AM
Get the latest insights from #DGHO2025 over on our YouTube channel! Watch Bernd Kasper discuss the most significant unmet needs and the importance of understanding the lived experience of people with desmoid tumors #MedSky #OncSky
ow.ly/e52g50XicbB
ow.ly/e52g50XicbB
Heading to #ACR25 or just keeping up with the latest in #rheumatology? Check out Medthority for the opportunity to earn #CME credit with our new HLH/MAS masterclass from Fabrizio de Benedetti featuring insights on diagnosis and treatment strategies #MedSky
ow.ly/sNW750XgZJo
ow.ly/sNW750XgZJo
October 24, 2025 at 1:33 PM
Heading to #ACR25 or just keeping up with the latest in #rheumatology? Check out Medthority for the opportunity to earn #CME credit with our new HLH/MAS masterclass from Fabrizio de Benedetti featuring insights on diagnosis and treatment strategies #MedSky
ow.ly/sNW750XgZJo
ow.ly/sNW750XgZJo